Next Article in Journal
The 6-Month Antibody Durability of Heterologous Convidecia Plus CoronaVac and Homologous CoronaVac Immunizations in People Aged 18–59 Years and over 60 Years Based on Two Randomized Controlled Trials in China
Next Article in Special Issue
Safety and Immunogenicity of the Convacell® Recombinant N Protein COVID-19 Vaccine
Previous Article in Journal
COVID-19 Vaccination and Immunosuppressive Therapy in Immune-Mediated Inflammatory Diseases
Previous Article in Special Issue
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Vaccines
Volume 11
Issue 12
10.3390/vaccines11121814
Version Notes
vaccines-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Article

Article Versions Notes

Vaccines 2023, 11(12), 1814; https://doi.org/10.3390/vaccines11121814
Action Date Notes Link
article xml file uploaded 4 December 2023 08:17 CET Original file -
article xml uploaded. 4 December 2023 08:17 CET Update https://www.mdpi.com/2076-393X/11/12/1814/xml
article pdf uploaded. 4 December 2023 08:17 CET Version of Record https://www.mdpi.com/2076-393X/11/12/1814/pdf
article supplementary file uploaded. 4 December 2023 08:17 CET - https://www.mdpi.com/2076-393X/11/12/1814#supplementary
article html file updated 4 December 2023 08:18 CET Original file https://www.mdpi.com/2076-393X/11/12/1814/html
Back to TopTop